Other Search Results
Oct 05, 2009 -
David Beckham was shirtless and scruffy at the end of the Galaxy's home game against the Chicago Fire on Friday night. He helped lead the team into a victory before fielding more questions about his career move plans. Becks is heading to England this week for two more World Cup qualifying matches and he's still finalizing the details of his return to AC Milan.
- 4 Comments
Sep 15, 2009 -
Shopping for a nursing bra should be as thrilling as a trip to Victoria's Secret! The "uniboob" contraptions of the past have been replaced by comfortable, cute and easy-to-use undergarments that are as fashionable as they are functional making the task of choosing a bra easier than ever. We recently sat down with some experienced sales help at Destination Maternity to discuss what expectant mamas should look for in a nursing bra.
- 5 Comments
Aug 31, 2009 -
As children, many girls dream of having babies at the same time as their best friend. While it's a nice concept, it rarely works out so perfectly. Geography, age, significant others, and life get in the way making it more common for women to enter motherhood at different times.
- 11 Comments
Jul 23, 2009 -
Chaotic as things may appear behind a Starbucks counter, every drink is made custom and to order in a systematic, organized way. I know this because I spent an afternoon as a Starbucks barista. Laurel Village Starbucks store manager Deanna Barbagiovvanni put me to work yesterday behind the espresso machines.
- 22 Comments
Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- Oral Contraception
- Implant Contraception
- Injected Contraception
- Intrauterine Devices (IUDs)...
- Spermicidal and Barrier Con...
- Natural Family Planning Met...
- Emergency Contraception
- Female Sterilization
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
First "No-Period" Birth Control Pill Approved
In May 2007, the Food and Drug Administration approved Lybrel, the first birth control pill that completely eliminates monthly menstrual periods. Lybrel contains low doses of the estrogen estradiol and the progestin levonorgestrol. The active pills are taken 365 days a year with no inactive pill breaks.
- 1 Comment
Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- Prognosis
- Causes
- Risk Factors
- Diagnosis
- Managing Tension-Type Heada...
- Medications
- Treatment
- Lifestyle Changes
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
Global Prevalence of Tension-Type Headache
Tension-type headaches account for nearly half of all headaches, according to a 2007 study in Cephalagia. The researchers estimated that more people are disabled by tension-type headache than by migraine.
Causes of Tension-Type Headaches
Doctors are not really sure why tension-type headaches occur.
- 2 Comments
Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- Stress Incontinence
- Urge Incontinence
- Overflow Incontinence
- Functional Incontinence
- Risk Factors
- Diagnosis
- Prognosis
- Treatment
- Lifestyle Changes
- Other Treatments
- Behavioral Treatments
- Medications
- Surgery
- Other Procedures
- Catheters and Collection De...
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
Sling Procedure Versus Burch Colposuspension
The sling procedure is better than Burch colposuspension in treating stress incontinence but may cause more post-operative urinary complications, according to results from an important 2007 New England Journal of Medicine study. In the first large-scale clinical trial to directly compare these two types of surgery, 47% of women who underwent the sling procedure had no urinary incontinence 2 years after surgery, compared with 38% of women who received the Burch procedure. However, 63% of women who had the sling procedure (and 47% of women who underwent the Burch procedure) experienced urinary tract infections following surgery.
- 0 Comments
Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- Causes
- Symptoms
- Fractures
- Risk Factors
- Diagnosis
- Lifestyle Changes
- Medications
- Treatment
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
Drug Approvals
- In 2007, the Food and Drug Administration (FDA) approved zoledronic acid (Reclast) for postmenopausal osteoporosis treatment. Zoledronic acid is given as an injection once a year. A 2007 study in the New England Journal of Medicine indicated that zoledronic acid can significantly reduce the risk of spine, hip, and other fractures.
- In 2007, the FDA approved raloxifene (Evista) for prevention of breast cancer in postmenopausal women with osteoporosis and postmenopausal women at high risk for breast cancer.
- 1 Comment